AI
GH icon

Atria Investments’s Guardant Health GH Stock Holding History

Atria Investments’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Sell
1,355
-884
-39% -$96.1K ﹤0.01% 2061
2026
Q1 		$207K Sell
2,239
-118
-5% -$11.8K ﹤0.01% 1960
2025
Q4 		$241K Sell
2,357
-1,457
-38% -$130K ﹤0.01% 1873
2025
Q3 		$238K Sell
3,814
-198
-5% -$10.8K ﹤0.01% 1850
2025
Q2 		$209K Buy
+4,012
New +$179K ﹤0.01% 1904
2020
Q2 		– Sell
-3,987
Closed -$277K – 634
2020
Q1 		$277K Buy
+3,987
New +$306K 0.02% 452

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Atria Investments's GH Position: Q2 2026 in Review

Atria Investments reduced its Guardant Health (GH) stake by 39% in Q2 2026, selling an estimated $96.1K and leaving 1,355 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

Atria Investments first reported a position in GH in Q1 2020 and has held it in 6 quarters since. The position peaked at $277K in Q1 2020. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Atria Investments held 1,355 shares of Guardant Health worth $203K as of Q2 2026.
  • Atria Investments sold 884 Guardant Health shares in Q2 2026, an estimated $96.1K.
  • Guardant Health made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #2061 holding.
  • Atria Investments first reported a position in Guardant Health in Q1 2020 and has held it in 6 quarters since.
  • Atria Investments's Guardant Health position peaked at $277K in Q1 2020.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.